Adverse Events and Perception of Benefit From Duloxetine for Treating Aromatase Inhibitor-Associated Arthralgias

BACKGROUND: Duloxetine effectively treats aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) in women with breast cancer but causes low-grade toxicities. This secondary analysis examines the relationship between adverse events (AE) and patient-perceived benefit, based on patient self-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnell, Patrick M, Lustberg, Maryam B, Henry, N Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023424/
https://www.ncbi.nlm.nih.gov/pubmed/33842832
http://dx.doi.org/10.1093/jncics/pkab018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023424/
https://www.ncbi.nlm.nih.gov/pubmed/33842832
http://dx.doi.org/10.1093/jncics/pkab018

Ejemplares similares